These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 28982886)

  • 1. Parenchymal Liver Blood Volume and Dynamic Volume Perfusion CT Measurements of Hepatocellular Carcinoma in Patients Undergoing Transarterial Chemoembolization.
    Rathmann N; Kara K; Budjan J; Henzler T; Smakic A; Schoenberg SO; Diehl SJ
    Anticancer Res; 2017 Oct; 37(10):5681-5685. PubMed ID: 28982886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Texture Analysis Parameter for Response Prediction in Patients with Hepatocellular Carcinoma Undergoing Drug-eluting Bead Transarterial Chemoembolization (DEB-TACE) Using Biphasic Contrast-enhanced CT Image Data: Correlation with Liver Perfusion CT.
    Kloth C; Thaiss WM; Kärgel R; Grimmer R; Fritz J; Ioanoviciu SD; Ketelsen D; Nikolaou K; Horger M
    Acad Radiol; 2017 Nov; 24(11):1352-1363. PubMed ID: 28652049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volume perfusion computed tomography (VPCT)-based evaluation of response to TACE using two different sized drug eluting beads in patients with nonresectable hepatocellular carcinoma: Impact on tumor and liver parenchymal vascularisation.
    Kaufmann S; Horger T; Oelker A; Beck S; Schulze M; Nikolaou K; Ketelsen D; Horger M
    Eur J Radiol; 2015 Dec; 84(12):2548-54. PubMed ID: 26428842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Efficacy of Cone-Beam CT-Based Liver Perfusion Mapping to Predict Initial Response of Hepatocellular Carcinoma to Transarterial Chemoembolization.
    Kim KA; Choi SY; Kim MU; Baek SY; Park SH; Yoo K; Kim TH; Kim HY
    J Vasc Interv Radiol; 2019 Mar; 30(3):358-369. PubMed ID: 30819478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma.
    Chen G; Ma DQ; He W; Zhang BF; Zhao LQ
    World J Gastroenterol; 2008 Oct; 14(37):5738-43. PubMed ID: 18837093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of volume perfusion computed tomography and contrast-enhanced ultrasound for assessment of therapeutic effect of transarterial chemoembolization in patients with hepatocellular carcinoma: a preliminary report.
    Kaufmann S; Schulze M; Spira D; Horger M
    Acta Radiol; 2016 Jan; 57(1):8-12. PubMed ID: 25585848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients.
    Ippolito D; Fior D; Bonaffini PA; Capraro C; Leni D; Corso R; Sironi S
    Eur J Radiol; 2014 Sep; 83(9):1665-71. PubMed ID: 24962900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic value of computed tomographic perfusion imaging of whole liver for quantitative assessment of blood flow state in liver cancer after transcatheter arterial chemoembolization].
    Li SM; Gao ZL; Lyu XT; Jia J; Zhu P; Chen Y; Liu YL; Zhang ZX
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):429-435. PubMed ID: 30317756
    [No Abstract]   [Full Text] [Related]  

  • 9. Transarterial Chemoembolization of Hepatocellular Carcinoma Using Radiopaque Drug-Eluting Embolics: How to Pursue Periprocedural Cross-Sectional Imaging?
    Ruff C; Grözinger G; Syha R; Elser S; Partovi S; Bitzer M; Horger M; Nikolaou K; Grosse U
    J Vasc Interv Radiol; 2019 Mar; 30(3):380-389.e4. PubMed ID: 30819480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parenchymal Blood Volume Assessed by C-Arm-Based Computed Tomography in Immediate Posttreatment Evaluation of Drug-Eluting Bead Transarterial Chemoembolization in Hepatocellular Carcinoma.
    Syha R; Grözinger G; Grosse U; Maurer M; Zender L; Horger M; Nikolaou K; Ketelsen D
    Invest Radiol; 2016 Feb; 51(2):121-6. PubMed ID: 26488373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computed tomography perfusion imaging for monitoring transarterial chemoembolization of hepatocellular carcinoma.
    Marquez HP; Karalli A; Haubenreisser H; Mathew RP; Alkadhi H; Brismar TB; Henzler T; Fischer MA
    Eur J Radiol; 2017 Jun; 91():160-167. PubMed ID: 28629564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between tumor perfusion and lipiodol deposition in hepatocellular carcinoma after transarterial chemoembolization.
    Yang L; Zhang XM; Zhou XP; Tang W; Guan YS; Zhai ZH; Dong GL
    J Vasc Interv Radiol; 2010 Dec; 21(12):1841-6. PubMed ID: 20980165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-dimensional parametric parenchymal blood flow in transarterial chemoembolisation for hepatocellular carcinoma: perfusion change quantification and tumour response prediction at 3 months post-intervention.
    Becker LS; Maschke SK; Dewald CLA; Meine TC; Winther HBM; Kirstein MM; Kloeckner R; Meyer BC; Wacker F; Hinrichs JB
    Clin Radiol; 2021 Feb; 76(2):160.e27-160.e33. PubMed ID: 33028487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose Optimization of Perfusion-derived Response Assessment in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: Comparison of Volume Perfusion CT and Iodine Concentration.
    Thaiss WM; Haberland U; Kaufmann S; Hepp T; Schulze M; Blum AC; Ketelsen D; Nikolaou K; Horger M; Sauter AW
    Acad Radiol; 2019 Sep; 26(9):1154-1163. PubMed ID: 30482626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma: usefulness of contrast saturation features on cone-beam computed tomography imaging for predicting short-term tumor response.
    Suk Oh J; Jong Chun H; Gil Choi B; Giu Lee H
    J Vasc Interv Radiol; 2013 Apr; 24(4):483-9. PubMed ID: 23452553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computed Tomography Perfusion Following Transarterial Chemoembolization of Hepatocellular Carcinoma: A Feasibility Study in the Early Period.
    Wimmer T; Steiner J; Talakic E; Stauber R; Quehenberger F; Portugaller RH; Schoellnast H
    J Comput Assist Tomogr; 2017; 41(5):708-712. PubMed ID: 28296685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of hepatocellular carcinoma (HCC) lesions using a novel CT-based volume perfusion (VPCT) technique.
    Kaufmann S; Horger T; Oelker A; Kloth C; Nikolaou K; Schulze M; Horger M
    Eur J Radiol; 2015 Jun; 84(6):1029-35. PubMed ID: 25816994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraprocedural C-arm dual-phase cone-beam CT: can it be used to predict short-term response to TACE with drug-eluting beads in patients with hepatocellular carcinoma?
    Loffroy R; Lin M; Yenokyan G; Rao PP; Bhagat N; Noordhoek N; Radaelli A; Blijd J; Liapi E; Geschwind JF
    Radiology; 2013 Feb; 266(2):636-48. PubMed ID: 23143027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of perfusion reduction by using 2D-perfusion angiography following transarterial chemoembolization with drug-eluting beads.
    Maschke SK; Werncke T; Klöckner R; Rodt T; Renne J; Kirstein MM; Vogel A; Wacker FK; Meyer BC; Hinrichs JB
    Abdom Radiol (NY); 2018 May; 43(5):1245-1253. PubMed ID: 28840307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.
    Li JJ; Zheng JS; Cui SC; Cui XW; Hu CX; Fang D; Ye LC
    World J Gastroenterol; 2015 Mar; 21(10):3035-40. PubMed ID: 25780303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.